1. Home
  2. FRGT vs VIVS Comparison

FRGT vs VIVS Comparison

Compare FRGT & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freight Technologies Inc.

FRGT

Freight Technologies Inc.

HOLD

Current Price

$5.22

Market Cap

2.6M

ML Signal

HOLD

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

SELL

Current Price

$0.86

Market Cap

2.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FRGT
VIVS
Founded
2015
2007
Country
Mexico
United States
Employees
N/A
9
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
2.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
FRGT
VIVS
Price
$5.22
$0.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
87.5K
114.1K
Earning Date
05-20-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
96.85
N/A
EPS
N/A
N/A
Revenue
$13,728,922.00
N/A
Revenue This Year
$371.03
$42.38
Revenue Next Year
N/A
$15.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.78
52 Week High
$5.90
$5.30

Technical Indicators

Market Signals
Indicator
FRGT
VIVS
Relative Strength Index (RSI) 65.75 35.05
Support Level $0.80 $0.78
Resistance Level $5.90 $1.88
Average True Range (ATR) 0.52 0.14
MACD 0.03 -0.01
Stochastic Oscillator 95.21 10.57

Price Performance

Historical Comparison
FRGT
VIVS

About FRGT Freight Technologies Inc.

Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: